Cold Spring Harbor (CSHL) in Cold Spring Harbor, Long Island, NY announced an affiliation with North Shore LIJ Health System. The new alliance is meant to spur cancer research and bring experimental treatments to the bedside.
In a venture that could bring experimental cancer treatments to more patients in the New York City metropolitan area, Cold Spring Harbor (CSHL) in Cold Spring Harbor, Long Island, NY and North Shore-LIJ Health System announced a new research and treatment affiliation.
The new “strategic alliance” is meant to bring promising cancer research developments to the bedside, and to attract investment that will facilitate more clinical trials.
Many large hospital systems are partnering with or starting up research facilities in this “translational medicine” paradigm.
The hospital system is making other changes to further cancer research and treatment, North Shore-LIJ Chief Executive Officer Michael Dowling said.
“Bringing the scientists of Cold Spring Harbor Laboratory together with the more than 200 academic oncologists and clinics of the North Shore-LIJ Cancer Institute will transform our approach to cancer research and treatment throughout the New York area,” Dowling said.
The health system, which has facilities on Long Island, in Westchester County and in New York City is investing more than $120 million in cancer research, diagnosis and treatment.
Over the past 2 years it completed an $84 million expansion of its Cancer Institute in Lake Success, NY and is building a $34 million outpatient center in Bay Shore, NY. It has invested more than $175 million in expanding cancer treatment throughout its system.
Cold Spring Harbor Laboratory is a US National Cancer Institute-designated Cancer Center and has been home to 8 scientists have won the Nobel Prize.
The institution has a long history of molecular and genetic research, including cancer research.
James Watson, the discoverer of the double helix structure of DNA, was once its director.